307 related articles for article (PubMed ID: 10091748)
1. The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors.
Maitra A; Yashima K; Rathi A; Timmons CF; Rogers BB; Shay JW; Gazdar AF
Cancer; 1999 Feb; 85(3):741-9. PubMed ID: 10091748
[TBL] [Abstract][Full Text] [Related]
2. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
Krajewski S; Chatten J; Hanada M; Reed JC
Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790
[TBL] [Abstract][Full Text] [Related]
4. Expression of telomerase mRNA component (hTR) in transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Kawai T; Hiroi S; Kumaki F; Torikata C; Aurues T; Ikeda T
Cancer; 1999 Nov; 86(10):2109-16. PubMed ID: 10570439
[TBL] [Abstract][Full Text] [Related]
5. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.
Poremba C; Heine B; Diallo R; Heinecke A; Wai D; Schaefer KL; Braun Y; Schuck A; Lanvers C; Bànkfalvi A; Kneif S; Torhorst J; Zuber M; Köchli OR; Mross F; Dieterich H; Sauter G; Stein H; Fogt F; Boecker W
J Pathol; 2002 Oct; 198(2):181-9. PubMed ID: 12237877
[TBL] [Abstract][Full Text] [Related]
6. Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma.
Yashima K; Milchgrub S; Gollahon LS; Maitra A; Saboorian MH; Shay JW; Gazdar AF
Clin Cancer Res; 1998 Jan; 4(1):229-34. PubMed ID: 9516976
[TBL] [Abstract][Full Text] [Related]
7. High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor.
Dome JS; Chung S; Bergemann T; Umbricht CB; Saji M; Carey LA; Grundy PE; Perlman EJ; Breslow NE; Sukumar S
Cancer Res; 1999 Sep; 59(17):4301-7. PubMed ID: 10485476
[TBL] [Abstract][Full Text] [Related]
8. Detection of human telomerase RNA in the tumour-surrounding mucosa of bladder carcinomas as a marker for premalignant transformation.
Leuenroth S; Riethdorf S; Erbersdobler A; Riethdorf L; Löning T; Huland H; Friedrich MG
BJU Int; 2005 Sep; 96(4):553-7. PubMed ID: 16104909
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of cell proliferation in human neuroblastoma: comparison with other prognostic factors.
Mejía C; Navarro S; Pellín A; Ruíz A; Castel V; Llombart-Bosch A
Oncol Rep; 2003; 10(1):243-7. PubMed ID: 12469176
[TBL] [Abstract][Full Text] [Related]
10. Discrepant flow cytometric expression and function of P-glycoprotein in neuroblastic tumors.
De Moerloose B; Dhooge C; Laureys G; Benoit Y; Demarche M; Devalck C; Plantaz D; Leroy J; Philippé J
Cytometry; 1999 Oct; 37(2):125-32. PubMed ID: 10486524
[TBL] [Abstract][Full Text] [Related]
11. Telomerase expression in sebaceous carcinoma of the eyelid.
Li B; Li ND; Xu XL; Zheng BH; Sun XL; Li LQ; Chen CX
Chin Med J (Engl); 2004 Mar; 117(3):445-8. PubMed ID: 15043789
[TBL] [Abstract][Full Text] [Related]
12. Implications of prognostic markers in brain tumors.
Grzybicki DM; Moore SA
Clin Lab Med; 1999 Dec; 19(4):833-47. PubMed ID: 10572718
[TBL] [Abstract][Full Text] [Related]
13. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Goto S; Umehara S; Gerbing RB; Stram DO; Brodeur GM; Seeger RC; Lukens JN; Matthay KK; Shimada H
Cancer; 2001 Nov; 92(10):2699-708. PubMed ID: 11745206
[TBL] [Abstract][Full Text] [Related]
14. High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor.
Dome JS; Bockhold CA; Li SM; Baker SD; Green DM; Perlman EJ; Hill DA; Breslow NE
J Clin Oncol; 2005 Dec; 23(36):9138-45. PubMed ID: 16172460
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the proliferative activity in neuroblastoma.
Rudolph P; Lappe T; Hero B; Berthold F; Parwaresch R; Harms D; Schmidt D
Am J Pathol; 1997 Jan; 150(1):133-45. PubMed ID: 9006330
[TBL] [Abstract][Full Text] [Related]
16. Conventional versus modified morphologic criteria for ganglioneuroblastoma. A review of cases from the Pediatric Oncology Group.
Joshi VV; Cantor AB; Altshuler G; Cohen LJ; Larkin EW; Shuster JJ; Rao PV; Holbrook CT; Hayes FA; Castleberry RP
Arch Pathol Lab Med; 1996 Sep; 120(9):859-65. PubMed ID: 9140292
[TBL] [Abstract][Full Text] [Related]
17. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H
Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780
[TBL] [Abstract][Full Text] [Related]
18. Expression of the RNA component of human telomerase in adult testicular germ cell neoplasia.
Delgado R; Rathi A; Albores-Saavedra J; Gazdar AF
Cancer; 1999 Nov; 86(9):1802-11. PubMed ID: 10547554
[TBL] [Abstract][Full Text] [Related]
19. A developmental model of neuroblastoma: differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage.
Hoehner JC; Gestblom C; Hedborg F; Sandstedt B; Olsen L; Påhlman S
Lab Invest; 1996 Nov; 75(5):659-75. PubMed ID: 8941212
[TBL] [Abstract][Full Text] [Related]
20. Tumors of the neuroblastoma group.
Shimada H
Pathology (Phila); 1993; 2(1):43-59. PubMed ID: 9420930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
